Article by M. Monsalve, coordinator of TREATMENT, for SEBBM

A brief summary of an article published in Redox Biology where it is been showed that the mitohormesis loss is enough to induce the metabolic adaptations associated with the tumor aggressiveness.

Read More

Second Generation Antipsychotics impact in insulin secretion and beta cell function might mediate prediabetes development

Last September, the 18th, our ESR3 Diana Grajales performed an amazing seminar entitled as you can see above.

Read More

Evaluation of genetic polymorphisms associated with the metabolic effects of olanzapine and aripiprazole

Our ESR, Dora Koller, defended her Ph.D. dissertation on July 23 in the Faculty of Medicine (Universidad Autónoma, Madrid). Her work, whose title is “Evaluation of genetic polymorphisms associated with the metabolic effects of olanzapine and aripiprazole” achieved the best […]

Read More

Mónica Ruiz, our ESR13, in Madrid Science Fair 2019

This is an event to promote science and encourage citizens to participate in scientific activities. Our ESR13, Mónica Ruíz, participated in the Madrid Science Fair MSCA stand organized by “La Fundación para el Conociemiento madri+d” talking about her experience as […]

Read More

OPEN POSITION ESR7

Read More

OPEN POSITION ESR5

Early Stage Research Position #5 available in Marie Skłodowska-Curie action Innovative Training Network “TREATMENT” (H2020-MSCA-ITN -721236) European Training Network: Metabolic Dysfunctions associated with Pharmacological Treatment of Schizophrenia. Located in Uppsala, Sweden

Read More

ITN TREATMENT at the 9th European Researchers Night in Coimbra

Giada Di Nunzio (ESR8) and Raphael Santamaria (ESR7) participated in the European Researchers Nigh 2018 at the CNC in Coimbra. The activity was focused on the NAFL disease via very interesting interactive games, demonstrations and public engagement. At CNC Açucarómetro/Gordurómetro […]

Read More